Internal Medicine, Hematology & Oncology · San Antonio, TX
NPI
1255375531
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1200 Brooklyn Ave, Suite #115
San Antonio, TX, 78212
Phone (210) 242-6531
Groups this clinician bills Medicare through
Medicare paid, 2024
$941K
99,702 services
Medicare patients, 2024
376
Average age 75
Drug cost, 2024
$5.7M
1,436 prescriptions
Company payments, 2025
$195
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anu Dham was code J9263 (injection, oxaliplatin, 0.5 mg), 20,710 times for 11 patients. In total Anu Dham billed 99,702 services in 143 codes, and Medicare paid $941K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 20,710 | 11 | $0.06 | $1,144 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 13,200 | 19 | $0.10 | $1,376 |
| J1756 Injection, iron sucrose, 1 mg | Office | 6,800 | 17 | $0.18 | $1,210 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 4,750 | 12 | $2.22 | $11K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,736 | 23 | $0.08 | $229 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,640 | 31 | $0.08 | $139 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,100 | 25 | $0.68 | $745 |
| J9190 Injection, fluorouracil, 500 mg | Office | 814 | 18 | $2.17 | $1,769 |
| 85025 Blood Count | Office | 556 | 161 | $7.52 | $4,179 |
| 80053 Clinical Chemistry | Office | 544 | 164 | $10.27 | $5,585 |
| 36415 Venipuncture Blood Collection | Office | 515 | 157 | $8.65 | $4,455 |
| 99214 Office E&M - Established | Office | 412 | 163 | $88.44 | $36K |
| 96367 Intravenous Infusion, Hydration | Office | 260 | 32 | $19.97 | $5,192 |
| 99213 Office E&M - Established | Office | 247 | 153 | $59.59 | $15K |
| 96413 Chemotherapy Administration | Office | 175 | 40 | $89.98 | $16K |
By year: 2022 $1.0M for 77,453 services; 2023 $1.2M for 85,120 services; 2024 $941K for 99,702 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 556 | 161 | $7.52 | $4,179 |
| 80053 Clinical Chemistry | 544 | 164 | $10.27 | $5,585 |
| 36415 Venipuncture Blood Collection | 515 | 157 | $8.65 | $4,455 |
| 82378 Clinical Chemistry | 132 | 37 | $18.48 | $2,440 |
| 82784 Immunoassay | 126 | 29 | $8.92 | $1,124 |
| 83521 Immunoassay | 110 | 24 | $16.64 | $1,831 |
| 82728 Clinical Chemistry | 64 | 38 | $13.03 | $834 |
| 83540 Clinical Chemistry | 64 | 38 | $6.18 | $396 |
| 83550 Clinical Chemistry | 64 | 38 | $8.36 | $535 |
| 83615 Clinical Chemistry | 58 | 33 | $5.92 | $343 |
Medicare prescription drug claims, 2024
In 2024, the drug Anu Dham prescribed most often to Medicare patients was Anastrozole, with 248 prescriptions and refills. In total Anu Dham wrote 1,436 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 248 | 637 | 70 | $3,346 |
| Acyclovir Generic | 83 | 87 | 15 | $560 |
| Eliquis Apixaban | 70 | 106 | 21 | $60K |
| Hydroxyurea Generic | 67 | 128 | 15 | $1,485 |
| Gabapentin Generic | 64 | 82 | 21 | $590 |
| Letrozole Generic | 49 | 104 | 14 | $936 |
| Calquence Acalabrutinib Maleate | 46 | 46 | Under 11 | $702K |
| Jakafi Ruxolitinib Phosphate | 41 | 41 | Under 11 | $586K |
| Prednisone Generic | 41 | 45 | 17 | $171 |
| Pomalyst Pomalidomide | 35 | 35 | Under 11 | $728K |
| Brukinsa Zanubrutinib | 34 | 34 | Under 11 | $499K |
| Imatinib Mesylate Generic | 29 | 29 | Under 11 | $41K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 25 | 25 | 16 | $656 |
| Revlimid Lenalidomide | 24 | 24 | Under 11 | $426K |
| Xarelto Rivaroxaban | 23 | 38 | Under 11 | $21K |
Brand drugs: 432 claims; generic drugs: 1,004 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anu Dham $195 ($195 in general payments such as food, travel and fees) from 7 companies. The largest payer was Novartis Pharmaceuticals Corporation with $60.15.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.